Evidence map›Paper›PMID 25955494›Full record

ArticlePloS one2015

Cost-minimization model of a multidisciplinary antibiotic stewardship team based on a successful implementation on a urology ward of an academic hospital.

Jan-Willem H Dik, Ron Hendrix, Alex W Friedrich, Jos Luttjeboer, Prashant Nannan Panday, Kasper R Wilting, Jerome R Lo-Ten-Foe, Maarten J Postma, Bhanu Sinha

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review.Antimicrobial resistance and infection control · 2019
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jan-Willem H DikDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Ron HendrixDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands; Certe Laboratory for Infectious Diseases, Groningen, the Netherlands.
Alex W FriedrichDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Jos LuttjeboerDepartment of Pharmacy, Unit of PharmacoEpidemiology & PharmacoEconomics, University of Groningen, Groningen, the Netherlands.
Prashant Nannan PandayDepartment of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, the Netherlands.
Kasper R WiltingDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Jerome R Lo-Ten-FoeDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.
Maarten J PostmaDepartment of Pharmacy, Unit of PharmacoEpidemiology & PharmacoEconomics, University of Groningen, Groningen, the Netherlands; Department of Epidemiology, University Medical Center Groningen, Groningen, the Netherlands.
Bhanu SinhaDepartment of Medical Microbiology, University of Groningen, University Medical Center Groningen, Groningen, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn order to stimulate appropriate antimicrobial use and thereby lower the chances of resistance development, an Antibiotic Stewardship Team (A-Team) has been implemented at the University Medical Center Groningen, the Netherlands. Focus of the A-Team was a pro-active day 2 case-audit, which was financially evaluated here to calculate the return on investment from a hospital perspective.

methodsEffects were evaluated by comparing audited patients with a historic cohort with the same diagnosis-related groups. Based upon this evaluation a cost-minimization model was created that can be used to predict the financial effects of a day 2 case-audit. Sensitivity analyses were performed to deal with uncertainties. Finally, the model was used to financially evaluate the A-Team.

resultsOne whole year including 114 patients was evaluated. Implementation costs were calculated to be €17,732, which represent total costs spent to implement this A-Team. For this specific patient group admitted to a urology ward and consulted on day 2 by the A-Team, the model estimated total savings of €60,306 after one year for this single department, leading to a return on investment of 5.9.

conclusionsThe implemented multi-disciplinary A-Team performing a day 2 case-audit in the hospital had a positive return on investment caused by a reduced length of stay due to a more appropriate antibiotic therapy. Based on the extensive data analysis, a model of this intervention could be constructed. This model could be used by other institutions, using their own data to estimate the effects of a day 2 case-audit in their hospital.

Indexed as

Anti-Bacterial AgentsCost-Benefit AnalysisDiagnosis-Related GroupsHospitalizationHospitals, UniversityHumansModels, EconomicNetherlandsReferral and ConsultationUrology Department, HospitalAnti-Bacterial Agents

Identifiers

PMID25955494
PMCPMC4425554

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.